ABBOTT LABORATORIES — Buyers Target $190Abbott Laboratories is setting up for a strong bullish recovery, with buyers expected to take control after the recent weakness.
The previous downside has created room for a substantial rebound, while the company's diversified healthcare business continues to provide a solid fundamental foundation.
Compare with Abbott Laboratories
3.11 USD
6.50 B USD
44.33 B USD
1.72 B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
IPO date
Mar 1, 1937
ISIN
US0028241000
CUSIP
002824100
FIGI
BBG000B9ZXB4
Identifiers
ISIN US0028241000
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
ABT | Continued stock growth- Timeframe: Weekly
- Trade type: Buy stop order
- Price: 104.18
- Take Profit: Open
- Stop Loss: 99.34 (-4.60 %)
Idea: Long on a breakout above last week's high - bullish momentum continuation.
Entry: Buy stop above last week’s high.
Stop-loss: Below the low of the same candle.
If the weekly candl
ABT: Sequence Target Hit & MSS — Path Toward WCLPrice on Abbott Laboratories ( ABT ) has officially completed its active bullish sequence, with the expansion leg reaching the defined Point C target zone ($115.00 – $120.00) . This culmination occurred directly within the higher-timeframe BC correction zone , creating an ideal confluence for stru
$ABT When the Reason for the Markdown ReversesWhat I'm seeing
ABT peaked ~$137 in mid-2025 and bled 40% to $81.97 a textbook Weinstein Stage 4 markdown while the broader market ran. The week of July 13 changed the tape: a massive bullish engulfing candle on the highest weekly volume in months, reclaiming $100 off the Fib 0% floor.
- Fib 0% ($
ABT — 60 Seconds Read
1️⃣ What do we see?
ABT has broken sharply above its EMA8, SMA20, SMA50 and SMA100 on strong volume. Relative strength is bullish and improving, and price reached a new three-month high. The move is real, but volatility is extreme and the declining SMA150 remains above price near $103.70.
2️⃣ Thes
38.2% Fibonacci Retest Buying Opportunity?The stock has shown a strong bounce after finding support near the 23.6% Fibonacci level, with previous support zone. Instead of buying after such a big green candle, Wait for a pullback toward $95.30 (FIB level 61.80). If buyers step in again and the price starts moving higher from there, it could
ABT | May, 2026 | The time to go long has come- Timeframe: Weekly
- Trade type: Buy stop order
- Price: 86.48
- Take Profit: Open
- Stop Loss: 81.97 (-5.20 %)
Idea: Long on a breakout above last week's high — bullish momentum continuation.
Entry: Buy stop above last week’s high.
Stop-loss: Below the low of the same candle.
If the weekly candle
Abbott LaboratoriesAbbott Laboratories operates within the healthcare and medical technology sector, with business exposure spanning diagnostics, medical devices, nutrition products, and pharmaceutical solutions. Due to the defensive nature of healthcare demand, the company is often viewed as structurally resilient ac
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateApr 15, 2043
Coupon4.75% (Fixed)
Maturity dateMar 15, 2066
Coupon5.60% (Fixed)
Maturity dateMar 15, 2056
Coupon5.50% (Fixed)
Maturity dateNov 30, 2046
Coupon4.90% (Fixed)
Maturity dateApr 15, 2043
Coupon4.75% (Fixed)
Maturity dateMay 27, 2040
Coupon5.30% (Fixed)
Maturity dateMar 15, 2038
Coupon4.75% (Fixed)
Maturity dateMar 15, 2036
Coupon4.65% (Fixed)
Maturity dateApr 1, 2039
Coupon6.00% (Fixed)
Maturity dateNov 30, 2036
Coupon4.75% (Fixed)
Maturity dateMar 15, 2033
Coupon4.30% (Fixed)
See all ABT bonds
Frequently asked questions
The current price of ABT is 102.36 USD — it has decreased by −1.03% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Abbott Laboratories stocks are traded under the ticker ABT.
ABT stock has fallen by −5.84% compared to the previous week, the month change is a −8.49% fall, over the last year Abbott Laboratories has showed a −22.31% decrease.
We've gathered analysts' opinions on Abbott Laboratories future price: according to them, ABT price has a max estimate of 135.00 USD and a min estimate of 103.00 USD. Watch ABT chart and read a more detailed Abbott Laboratories stock forecast: see what analysts think of Abbott Laboratories and suggest that you do with its stocks.
ABT stock is 1.77% volatile and has beta coefficient of −0.34. Track Abbott Laboratories stock price on the chart and check out the list of the most volatile stocks — is Abbott Laboratories there?
Today Abbott Laboratories has the market capitalization of 176.55 B, it has decreased by −4.53% over the last week.
Yes, you can track Abbott Laboratories financials in yearly and quarterly reports right on TradingView.
Abbott Laboratories is going to release the next earnings report on Oct 21, 2026. Keep track of upcoming events with our Earnings Calendar.
ABT earnings for the last quarter are 1.31 USD per share, whereas the estimation was 1.28 USD resulting in a 2.56% surprise. The estimated earnings for the next quarter are 1.42 USD per share. See more details about Abbott Laboratories earnings.
Abbott Laboratories revenue for the last quarter amounts to 12.59 B USD, despite the estimated figure of 12.52 B USD. In the next quarter, revenue is expected to reach 12.99 B USD.
ABT net income for the last quarter is 928.00 M USD, while the quarter before that showed 1.08 B USD of net income which accounts for 0.00% change. Track more Abbott Laboratories financial stats to get the full picture.
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (TTM)% is 2.43%. Tracking Abbott Laboratories dividends might help you take more informed decisions.
Abbott Laboratories dividend yield was 1.92% in 2025, and payout ratio reached 64.54%. The year before the numbers were 1.98% and 29.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 17, 2026, the company has 115 K employees. See our rating of the largest employees — is Abbott Laboratories on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Abbott Laboratories EBITDA is 11.11 B USD, and current EBITDA margin is 25.67%. See more stats in Abbott Laboratories financial statements.
Like other stocks, ABT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abbott Laboratories stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Abbott Laboratories technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Abbott Laboratories stock shows the sell signal. See more of Abbott Laboratories technicals for a more comprehensive analysis.









